About me
Health Regulation Expert with 11 years of experience monitoring non-clinical and clinical development of drugs and biological products, with a focus on monoclonal antibodies and vaccines. She is also Good Clinical Practice(GCP) inspector and participated as a representative of Anvisa in the working group for the development of the ICH E17 guideline "General principles for planning and design of multi-regional clinical trials" and in the implementation group and development of training materials for this same guideline. Currently, she participates as Anvisa's representative in the working group for Annex 2 of the ICH E6 (R3) guideline. With a degree in Biology and a Master's Degree in Molecular Biology, she has a solid scientific foundation.
